Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Slides:

Advertisements

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Endovascular therapy for acute limb ischemia

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Rafael D. Malgor, MD, Gustavo S. Oderich, MD, James C

Revascularization for acute mesenteric ischemia

Comparison of EVAR and open repair in patients with small abdominal aortic aneurysms: Can we predict results of the PIVOTAL trial? Purandath Lall, MBBS,

Femoral artery calcification as a determinant of success for percutaneous access for endovascular abdominal aortic aneurysm repair Jesse M. Manunga,

Outcomes of carotid artery stenting versus historical surgical controls for radiation- induced carotid stenosis Tiziano Tallarita, MD, Gustavo S. Oderich,

Stenting of femoropopliteal lesions using interwoven nitinol stents

Open surgery for atherosclerotic chronic mesenteric ischemia

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

IP181. Factors Affecting Limb Salvage Following Open and Endovascular Revascularization for Critical Limb Ischemia in a 10-Year Population-Based Study

Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia Gustavo S. Oderich, MD, Tiziano.

Endoscopic versus open saphenous vein graft harvest for lower extremity bypass in critical limb ischemia Raymond E. Eid, MD, Li Wang, MS, Michael Kuzman,

Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Woosup M. Park, MD, Peter Gloviczki, MD, Kenneth J. Cherry, MD, John W

Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Michael J. Singh, MD, Ronald Fairman, MD, Paul Anain, MD, William D

Anatomic feasibility of off-the-shelf fenestrated stent grafts to treat juxtarenal and pararenal abdominal aortic aneurysms Bernardo C. Mendes, MD, Gustavo.

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele.

Clinical presentation, comorbidities, and age but not female gender predict survival after endovascular repair of abdominal aortic aneurysm Peter Gloviczki,

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Magdiel Trinidad-Hernandez, MD, Joseph J

Mesenteric stenting for chronic mesenteric ischemia

Vascular interventions in head and neck cancer patients as a marker of poor survival Emilia Krol, MD, Colin T. Brandt, MD, Juliet Blakeslee-Carter, BS,

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Durability of open popliteal artery aneurysm repair

Interventions for mesenteric vasculitis

A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access Evan R. Brownie,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Michael P. Harlander-Locke, BS, Liv K. Harmon, MD, Peter F

Virendra I. Patel, MD, Mark F. Conrad, MD, Christopher J

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Ying Huang, MD, PhD, Peter Gloviczki, MD, Audra A

Benign superior vena cava syndrome: Stenting is now the first line of treatment Adnan Z. Rizvi, MD, Manju Kalra, MBBS, Haraldur Bjarnason, MD, Thomas.

Outcomes of reoperative open or endovascular interventions to treat patients with failing open mesenteric reconstructions for mesenteric ischemia Karina.

Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia

Chronic mesenteric ischemia: Treatment of recurrent disease

Revascularization of acute mesenteric ischemia after creation of a dedicated multidisciplinary center Arnaud Roussel, MD, Yves Castier, MD, PhD, Alexandre.

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Stent placement for treatment of central and peripheral venous obstruction: A long-term multi-institutional experience Gustavo S.C. Oderich, MD, Gerald.

Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia Panagiotis Kougias, MD, Donald Lau, BS,

Evaluation of the Endurant stent graft under instructions for use vs off-label conditions for endovascular aortic aneurysm repair Giovanni Torsello,

David H. Stone, MD, David C. Brewster, MD, Christopher J

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Eric K

Thrombotic mesenteric ischemia due to aortic dissection

Rabih A. Chaer, MD, Joel E. Barbato, MD, Stephanie C

Shaun M. Gifford, MD, Audra A. Duncan, MD, Lawrence E

Cassius Iyad Ochoa Chaar, MD, Michel S. Makaroun, MD, Luke K

Infected femorodistal bypass: Is graft removal mandatory?

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Emily A. Wood, MD, Manju Kalra, MD, Peter Gloviczki, MD, Audra A

A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions

Christopher L. Skelly, MD, Katherine Gallagher, BS, Ronald M

Catalin Harbuzariu, MD, Audra A. Duncan, MD, Thomas C

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease Tiziano Tallarita, MD, Gustavo S. Oderich, MD,

Efficacy of combined renal and mesenteric revascularization

Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era Evan J. Ryer, MD,

Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik.

Anatomical Feasibility of Off-the-Shelf Fenestrated Stent Grafts to Treat Juxtarenal and Pararenal Abdominal Aortic Aneurysms Bernardo Mendes, Gustavo.

Presentation transcript:

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke S. Erdoes, MD, Christopher LeSar, MD, Bernardo C. Mendes, MD, Peter Gloviczki, MD, Stephen Cha, MS, Audra A. Duncan, MD, Thomas C. Bower, MD Journal of Vascular Surgery Volume 58, Issue 5, Pages 1316-1324 (November 2013) DOI: 10.1016/j.jvs.2013.05.013 Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 1 Kaplan-Meier estimates of freedom from symptom recurrence in patients treated by primary interventions for chronic mesenteric ischemia (CMI) using bare metal stents (BMS) or covered stents (CS). Journal of Vascular Surgery 2013 58, 1316-1324DOI: (10.1016/j.jvs.2013.05.013) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 2 Kaplan-Meier estimates of freedom from reintervention in patients treated by primary interventions for chronic mesenteric ischemia (CMI) using bare metal stents (BMS) or covered stents (CS). Journal of Vascular Surgery 2013 58, 1316-1324DOI: (10.1016/j.jvs.2013.05.013) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 3 Kaplan-Meier estimates of primary (A) and secondary patency rates (B) in patients treated by primary interventions for chronic mesenteric ischemia (CMI) using bare metal stents (BMS) or covered stents (CS). Journal of Vascular Surgery 2013 58, 1316-1324DOI: (10.1016/j.jvs.2013.05.013) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 4 Kaplan-Meier estimates of primary (A) and secondary patency rates (B) in patients treated by reinterventions for chronic mesenteric ischemia (CMI) using bare metal stents (BMS) or covered stents (CS). The dotted line represents standard deviation >10%. Journal of Vascular Surgery 2013 58, 1316-1324DOI: (10.1016/j.jvs.2013.05.013) Copyright © 2013 Society for Vascular Surgery Terms and Conditions